CEL-SCI (CVM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CVM CEL-SCI

Watchlist

1.440
-0.010-0.69%

Close Apr 26 16:00 ET

1.450
+0.010+0.69%

Post 19:48 ET

77.73MMarket Cap-2086P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cel-Sci Corp Bolsters Board With Finance Expert Mario Gobbo
TipRanksApr 23 17:12 ET
CEL-SCI Appoints Mario Gobbo to Its Board of Directors
CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Mario Gobbo to its Board of Directors.
BusinesswireApr 23 09:00 ET
CEL-SCI Advances Cancer Therapy, Completes Manufacturing Facility
InvestingMar 6 09:17 ET
Express News | CEL-SCI Q1 EPS $(0.14) Up From $(0.18) YoY
Moomoo 24/7Feb 15 08:12 ET
Cel-Sci GAAP EPS of -$0.14
Seeking AlphaFeb 15 08:10 ET
Press Release: CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results VIENNA, Va.--(BUSINESS WIRE)--February 15, 2024-- CEL-SCI Corporation (NYSE American: CVM) today reported financial results fo
Dow JonesFeb 15 08:01 ET

Comments

Trytosaveabit

Feb 14 06:32

Offering closed!

$CEL-SCI(CVM.US)$ has released an update.
CEL-SCI Corporation has successfully completed an offering of 3,875,000 common stock shares at $2.00 each, raising $7.75 million before expenses. This capital will primarily fund the development of their Multikine product, as well as for general corporate purposes and working capital. The offering, which closed on February 13, 2024, was facilitated by ThinkEquity LLC, acting as the representative for the underwriters. The shares were sold...